Trial NCT04535102

View at ClinicalTrials.gov 
Org. Study IDs: 19-1195.cc
Secondary IDs: P30CA046934

Last trial update was posted on 2022-05-09

MeSH Interventions

Polatuzumab vedotin

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B Cell Lymphoma

Stopping Reasons

Lack of sufficient patient population

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID